Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT05114850
Recruiting Observational

Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

NCT05114850 · tracked via the Priya Life Science Germany tracker
Sponsor
P+F Products + Features GmbH
Phase
Observational
Started
2022-04-20
Last updated
2024-04-03

Condition(s) studied

Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid InsufficiencyHeart FailureHeart DiseasesHeart Valve Diseases

Study summary

Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Successful treatment with TricValve Transcatheter Bicaval Valves System * Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent Exclusion Criteria: * no exclusion criterion

Primary outcome measure(s)

  • Number of patients with readmission for HF — up to 12 months
    First unplanned readmission for Heart Failure

Trial sites (28)

FacilityCityRegionStatus
Universitätsklinikum St. Pölten Sankt Pölten Lower Austria Not Yet Recruiting
Medizinische Universität Wien, Department of Cardiac Surgery Vienna Austria Not Yet Recruiting
Medizinische Universität Wien, Universitätsklinik für Innere Medizin II Vienna Austria Not Yet Recruiting
Department of Cardiology, Algemeen Stedelijk Ziekenhuis (ASZ) Aalst Belgium Not Yet Recruiting
RkK gGmbH im Artemed Klinikverbund Freiburg Freiburg im Breisgau Germany Not Yet Recruiting
Universitätsklinikum Freiburg Freiburg im Breisgau Germany Not Yet Recruiting
Klinikum Friedrichshafen Friedrichshafen Germany Not Yet Recruiting
SLK-Kliniken Heilbronn GmbH Heilbronn Germany Not Yet Recruiting
Universitätsklinikum Regensburg Regensburg Germany Not Yet Recruiting
Robert-Bosch-Krankenhaus Stuttgart Germany Not Yet Recruiting
Rems-Murr-Kliniken Winnenden Germany Not Yet Recruiting
Cardiothoracic and Vascular Surgery Clinic of Hospital of LSMUH Kaunas Klinikos Kaunas Lithuania Not Yet Recruiting
Hospital de Galdakao-Usansolo Galdakao Bizkaia Not Yet Recruiting
Hospital Virgen de la Victoria Málaga Malaga Not Yet Recruiting
Parc de Salut Mar Barcelona Spain Recruiting
Hospital Clinic Barcelona Barcelona Spain Recruiting
Hospital Universitari de Bellvitge Barcelona Spain Not Yet Recruiting
Hospital Universitari Germans Trias i Pujol Barcelona Spain Recruiting
Hospital Universitario Reina Sofia de Córdoba Córdoba Spain Recruiting
Hospital Universitario Lucus Augusti Lugo Spain Recruiting
Hospital Universitario Puerta de Hierro de Majadahonda Madrid Spain Not Yet Recruiting
Hospital Clínico San Carlos Madrid Spain Recruiting
Hospital Universitario La Paz Madrid Spain Recruiting
Hospital Universitario Ramón y Cajal Madrid Spain Recruiting
Hospital Universitario Central Asturias Oviedo Spain Recruiting
Hospital Clínico Universitario de Salamanca Salamanca Spain Recruiting
Hospital Clínico Universitario de Valladolid Valladolid Spain Recruiting
Hospital Universitario Alvaro Cunqueiro Vigo Spain Recruiting

Other trials for the same condition

Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System Recruiting
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants Recruiting
Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND) Active, not recruiting
A Study on Remote Health Support for Patients With Heart Failure. Starting soon
Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05114850 on ClinicalTrials.gov ↗ ← All trials in Germany